These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 23344183

  • 21. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
    Oosterman JM, Vogels RL, van Harten B, Gouw AA, Scheltens P, Poggesi A, Weinstein HC, Scherder EJ.
    Brain Cogn; 2008 Nov; 68(2):128-33. PubMed ID: 18450353
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease.
    Jacobs HI, Van Boxtel MP, van der Elst W, Burgmans S, Smeets F, Gronenschild EH, Verhey FR, Uylings HB, Jolles J.
    J Alzheimers Dis; 2011 Nov; 25(3):477-90. PubMed ID: 21471642
    [Abstract] [Full Text] [Related]

  • 24. Medial temporal lobe atrophy in vascular dementia: visual temporal lobe rating scale.
    Cho H, Kwon JH, Seo HJ.
    Arch Gerontol Geriatr; 2009 Nov; 48(3):415-8. PubMed ID: 18468705
    [Abstract] [Full Text] [Related]

  • 25. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF, Wang H, Chu Y, Huang YC, Su MY.
    Dement Geriatr Cogn Disord; 2006 Nov; 22(2):177-84. PubMed ID: 16912479
    [Abstract] [Full Text] [Related]

  • 26. Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease.
    van der Vlies AE, Staekenborg SS, Admiraal-Behloul F, Prins ND, Barkhof F, Vrenken H, Reiber JH, Scheltens P, van der Flier WM.
    J Alzheimers Dis; 2013 Nov; 35(1):169-78. PubMed ID: 23364136
    [Abstract] [Full Text] [Related]

  • 27. Exploring the Spectrum of Subcortical Hyperintensities and Cognitive Decline.
    Chen YC, Tsao HH, Chu YC, Wang JJ, Lee JD, Chang PY, Hsu WC.
    J Neuropsychiatry Clin Neurosci; 2018 Nov; 30(2):130-138. PubMed ID: 29061091
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patients.
    Oudega ML, van Exel E, Wattjes MP, Comijs HC, Scheltens P, Barkhof F, Eikelenboom P, de Craen AJ, Beekman AT, Stek ML.
    Am J Geriatr Psychiatry; 2014 Feb; 22(2):157-66. PubMed ID: 23567440
    [Abstract] [Full Text] [Related]

  • 30. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
    Kim S, Choi SH, Lee YM, Kim MJ, Kim YD, Kim JY, Park JH, Myung W, Na HR, Han HJ, Shim YS, Kim JH, Yoon SJ, Kim SY, Kim DK.
    Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Modified Visual Magnetic Resonance Rating Scale for Evaluation of Patients with Forgetfulness.
    Yalciner BZ, Kandemir M, Taskale S, Tepe SM, Unay D.
    Can J Neurol Sci; 2019 Jan; 46(1):71-78. PubMed ID: 30417801
    [Abstract] [Full Text] [Related]

  • 34. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH, Lee ST, Kon Chu, Park HJ, Shim JY, Kim M.
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [Abstract] [Full Text] [Related]

  • 35. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study.
    Korf ES, van Straaten EC, de Leeuw FE, van der Flier WM, Barkhof F, Pantoni L, Basile AM, Inzitari D, Erkinjuntti T, Wahlund LO, Rostrup E, Schmidt R, Fazekas F, Scheltens P, LADIS Study Group.
    Diabet Med; 2007 Feb; 24(2):166-71. PubMed ID: 17257279
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. White matter predictors of cognitive functioning in older adults.
    Meier IB, Manly JJ, Provenzano FA, Louie KS, Wasserman BT, Griffith EY, Hector JT, Allocco E, Brickman AM.
    J Int Neuropsychol Soc; 2012 May; 18(3):414-27. PubMed ID: 22390883
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD.
    van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, Admiraal-Behloul F, Spilt A, Bollen EL, Westendorp RG, van Buchem MA.
    Neurology; 2004 May 25; 62(10):1862-4. PubMed ID: 15159496
    [Abstract] [Full Text] [Related]

  • 40. Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study.
    Galluzzi S, Talassi E, Belussi M, Scheltens P, van de Pol L, Nobili F, Rodriguez G, Froelich L, Damian M, Martinez-Lage P, Gomez-Isla T, Reynish E, Ousset PJ, Vellas B, Frisoni GB.
    Dement Geriatr Cogn Disord; 2008 May 25; 26(4):314-22. PubMed ID: 18841016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.